← Leaderboards
Mario Andres Blanco
Princeton University
$2,721,548
Attributed
$2,721,548
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $806.2K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,721,548 · 4
By mechanism
R01$2,001,625 · 1
K22$573,844 · 1
F31$82,090 · 1
F32$63,989 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularIn VivoCellsGenesChemotherapyDifferentiation TherapyProgramsMll-Af9MutantMyelogenousChromatinTherapeutic TargetBiochemicalGene ExpressionResponseEpigenetic ProcessHematologic NeoplasmsBurden Of IllnessComplexMouse ModelIn VitroChip-SeqHematopoiesisMass Spectrum Analysis
Grant awards (14)
Investigating the role of KAT6A in MLL-rearranged acute myeloid leukemia$733,489
R01 · FY2025 · CA · contact PI
Investigating the role of KAT6A in MLL-rearranged acute myeloid leukemia$72,750
R01 · FY2025 · CA · contact PI
Investigating the role of KAT6A in MLL-rearranged acute myeloid leukemia$351,393
R01 · FY2024 · CA · contact PI
Investigating the role of KAT6A in MLL-rearranged acute myeloid leukemia$69,113
R01 · FY2024 · CA · contact PI
Investigating the role of KAT6A in MLL-rearranged acute myeloid leukemia$36,375
R01 · FY2024 · CA · contact PI
Investigating the role of KAT6A in MLL-rearranged acute myeloid leukemia$365,525
R01 · FY2023 · CA · contact PI
Investigating the role of KAT6A in MLL-rearranged acute myeloid leukemia$372,980
R01 · FY2022 · CA · contact PI
The role of the histone chaperone Chaf1b in sustaining the Hoxa9-driven AML differentiation block$190,620
K22 · FY2020 · CA · contact PI
The role of the histone chaperone Chaf1b in sustaining the Hoxa9-driven AML differentiation block$191,254
K22 · FY2019 · CA · contact PI
The role of the histone chaperone Chaf1b in sustaining the Hoxa9-driven AML differentiation block$191,970
K22 · FY2018 · CA · contact PI
RNAi screen for chromatin regulators of differentiation in Acute Myeloid Leukemia$11,799
F32 · FY2014 · CA · contact PI
RNAi screen for chromatin regulators of differentiation in Acute Myeloid Leukemia$52,190
F32 · FY2013 · CA · contact PI
Functional Role of Metadherin Subcellular Localization in Breast Cancer$41,118
F31 · FY2009 · CA · contact PI
Functional Role of Metadherin Subcellular Localization in Breast Cancer$40,972
F31 · FY2008 · CA · contact PI